| Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral (s … GV Papatheodoridis, S Manolakopoulos, G Touloumi, G Vourli, ... Gut, gut. 2010.221846, 2011 | 224 | 2011 |
| Molecular epidemiology of hepatitis C virus (HCV) in Greece: Temporal trends in HCV genotype‐specific incidence and molecular characterization of genotype 4 isolates A Katsoulidou, V Sypsa, NC Tassopoulos, J Boletis, A Karafoulidou, ... Journal of viral hepatitis 13 (1), 19-27, 2006 | 117 | 2006 |
| Extensive psoriasis induced by pegylated interferon alpha-2b treatment for chronic hepatitis B. I Ketikoglou, S Karatapanis, I Elefsiniotis, G Kafiri, A Moulakakis European journal of dermatology: EJD 15 (2), 107-109, 2005 | 77 | 2005 |
| Impact of interferon‐alpha therapy on liver fibrosis progression in patients with HBeAg‐negative chronic hepatitis B GV Papatheodoridis, K Petraki, E Cholongitas, E Kanta, I Ketikoglou, ... Journal of viral hepatitis 12 (2), 199-206, 2005 | 56 | 2005 |
| Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV … V Sypsa, G Touloumi, NC Tassopoulos, I Ketikoglou, I Vafiadis, G Hatzis, ... Journal of viral hepatitis 11 (4), 366-374, 2004 | 54 | 2004 |
| The effect of adherence to therapy on sustained response in daily or three times a week interferon alpha‐2b plus ribavirin treatment of naive and nonresponder chronic hepatitis … M Raptopoulou, D Tsantoulas, I Vafiadi, I Ketikoglou, E Paraskevas, ... Journal of viral hepatitis 12 (1), 91-95, 2005 | 53 | 2005 |
| Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments V Sypsa, G Touloumi, GV Papatheodoridis, NC Tassopoulos, I Ketikoglou, ... JOURNAL OF HEPATOLOGY 40, 84-84, 2004 | 52 | 2004 |
| Hepatocellular carcinoma risk in HB eAg‐negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet. Greece cohort GV Papatheodoridis, S Manolakopoulos, G Touloumi, G Nikolopoulou, ... Journal of viral hepatitis 22 (2), 120-127, 2015 | 50 | 2015 |
| Future trends of HCV‐related cirrhosis and hepatocellular carcinoma under the currently available treatments V Sypsa, G Touloumi, GV Papatheodoridis, NC Tassopoulos, I Ketikoglou, ... Journal of viral hepatitis 12 (5), 543-550, 2005 | 47 | 2005 |
| Hepatic parenchyma resection using stapling devices: peri-operative and long-term outcome SG Delis, A Bakoyiannis, D Karakaxas, K Athanassiou, N Tassopoulos, ... HPB 11 (1), 38-44, 2009 | 39 | 2009 |
| Autoimmune pancreatitis I Ketikoglou, A Moulakakis Digestive and liver disease 37 (3), 211-215, 2005 | 33 | 2005 |
| Patient's age modifies the impact of the proposed predictors of sustained virological response in chronic hepatitis C patients treated with PEG-interferon plus ribavirin IS Elefsiniotis, C Pavlidis, I Ketikoglou, S Koutsounas, N Scarmeas, ... European journal of internal medicine 19 (4), 266-270, 2008 | 30 | 2008 |
| Listeria monocytogenes peritonitis: presentation, clinical features, treatment, and outcome GD Liatsos, S Thanellas, M Pirounaki, I Ketikoglou, A Moulakakis Scandinavian journal of gastroenterology 47 (10), 1129-1140, 2012 | 29 | 2012 |
| HEPNET. Greece Cohort Study Group. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with … GV Papatheodoridis, S Manolakopoulos, G Touloumi, G Vourli, ... Gut 60 (8), 1109-1116, 2011 | 27 | 2011 |
| Immunogenicity of recombinant hepatitis B vaccine in treatment-naive and treatment-experienced chronic hepatitis C patients: the effect of pegylated interferon plus ribavirin … IS Elefsiniotis, E Vezali, K Kamposioras, KD Pantazis, R Tontorova, ... World Journal of Gastroenterology: WJG 12 (27), 4420, 2006 | 25 | 2006 |
| Predictors of sustained virological response in Greek and Egyptian patients with hepatitis C genotype 4: does ethnicity matter? V Papastergiou, D Dimitroulopoulos, L Skorda, P Lisgos, I Ketikoglou, ... Journal of medical virology 84 (8), 1217-1223, 2012 | 24 | 2012 |
| Hepatitis C virus genotyping in Greece: unexpected high prevalence of genotype 5a in a Greek island S Karatapanis, P Tsoplou, V Papastergiou, A Vasiageorgi, M Stampori, ... Journal of medical virology 84 (2), 223-228, 2012 | 24 | 2012 |
| Hepatitis C virus survival curve analysis in naive patients treated with peginterferon alpha-2b plus ribavirin. A randomized controlled trial for induction with high doses of … K Mimidis, VP Papadopoulos, I Elefsiniotis, D Koliouskas, I Ketikoglou, ... JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES 15 (3), 213, 2006 | 24 | 2006 |
| Long‐term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg‐negative chronic hepatitis B patients S Manolakopoulos, A Striki, M Deutsch, M Mela, I Ketikoglou, ... Liver International 31 (10), 1525-1532, 2011 | 17 | 2011 |
| Possible green tea-induced thrombotic thrombocytopenic purpura GD Liatsos, A Moulakakis, I Ketikoglou, S Klonari American Journal of Health-System Pharmacy 67 (7), 531-534, 2010 | 16 | 2010 |
